Search Results
Jun 03, 2026, 13:07 ET SNEC 2026: APsystems демонстрирует ведущие в отрасли решения для накопления и хранения энергии для коммерческих и промышленных объектов
APstorage 241L, обеспечивающий мощную и стабильную долгосрочную работу. APstorage 241L — эффективное,
More news about: APsystems
Jun 03, 2026, 13:04 ET APsystems presenta soluciones líderes en la industria para el almacenamiento de energía en el sector C&I
APstorage 241L: almacenamiento eficiente, fiable y rentable para el sector C&IEl APstorage 241L ofrece una economía superior, un rendimiento estable y una mayor seguridad para aplicaciones C&I.
More news about: APsystems
Jun 03, 2026, 13:03 ET SNEC 2026: APsystems präsentiert branchenführende Energiespeicherlösungen für C&I
APstorage 241L – effizienter, zuverlässiger und kostengünstiger C&I-SpeicherDer APstorage 241L bietet überragende Wirtschaftlichkeit, stabile Leistung und verbesserte Sicherheit für Anwendungen in
More news about: APsystems
Jun 03, 2026, 13:01 ET SNEC 2026 : APsystems présente des solutions de stockage d'énergie C&I à la pointe de l'industrie
APstorage 241L - Stockage C&I efficace, fiable et rentableL'APstorage 241L offre une économie supérieure, des performances stables et une sécurité accrue pour les applications C&I. La
More news about: APsystems
Jun 03, 2026, 12:59 ET SNEC 2026: APsystems Showcases Industry-Leading C&I Energy Storage Solutions
APstorage 241L – Efficient, Reliable and Cost-Effective C&I StorageThe APstorage 241L delivers superior economy, stable performance, and enhanced safety for C&I applications. Its cabinet height
More news about: APsystems
Jun 03, 2026, 12:00 ET Neuro Launches Limited-Edition Watermelon Energy & Focus Gum for Summer
summer with the launch of its limited-edition Watermelon Energy & Focus Gum. The new flavor combines Neuro's signature blend of natural caffeine, L-theanine, B vitamins, and a juicy watermelon taste, delivering a balanced, zero-sugar boost to power summer days into evenings.
More news about: Neuro
Jun 03, 2026, 11:50 ET Last Mile Production Selects Fireblocks as Institutional Custody and Tokenization Infrastructure for LMCX Carbon Avoidance Token
deterministic data backed by physics and engineering," said Zach Wagner, CEO of Last Mile Production. "Building on a foundation that focuses on OGMP 2.0 L5 reporting means the highest accuracy and accounting of emissions. Layered on top is CAT custody and reserve management through Fireblocks, which means
More news about: CorpHQ
Jun 03, 2026, 10:34 ET THE 27TH ANNUAL BEST BUDDIES CHALLENGE: HYANNIS PORT PRESENTED BY JERSEY MIKE'S SUBS, SHAW'S AND STAR MARKET FOUNDATION AND THE TJX COMPANIES, INC. RAISES MORE THAN $4 MILLION TO SUPPORT PEOPLE WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES
ikes-subs-shaws-and-star-market-foundation-and-the-tjx-companies-inc-raises-more-than-4-million-to-support-people-with-intellectual-and-developmental--302789835.htmlSOURCE Best Buddies International
More news about: Best Buddies International
Jun 03, 2026, 10:21 ET KOMISJA EUROPEJSA ZATWIERDZA PREPARAT IMDYLLTRA® FIRMY AMGEN DO LECZENIA DROBNOKOMÓRKOWEGO RAKA PŁUCA W POSTACI ROZSIANEJ
https://www.clinicaltrials.gov/study/NCT05740566.Rudin CM, Mountzios GS, Sun L, et al. Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small-cell lung cancer: primary analysis of Ph3 DeLLphi-304 (Tarlatamab w porównaniu z chemioterapią (CTx) jako leczenie drugiego rzutu (2L) w drobnokomórkowym raku płuca: analiza pierwotna
More news about: Amgen
Jun 03, 2026, 10:03 ET Middle East & Africa Data Center Construction Market Poised for USD 15.97 Billion by 2031 -- Exclusive Insights by Arizton
GroupHubTechHill InternationalIngeniumICS NettInterkel GroupISF GroupISGJAMEDJames L WilliamsJohn Paul ConstructionKentLaing O'RourkeKinetic ControlsLaith Electro MechanicalLinesightLYT
More news about: Arizton Advisory & Intelligence
Jun 03, 2026, 10:00 ET RedThread Research State of L&D 2026: High-Performing Organizations Are Rewriting How L&D Works
moving in a direction L&D doesn't control. The methods employees rely on most for development, such as manager feedback and stretch assignments, are largely ones L&D doesn't own or control. For the first time in the study's history, none of the traditional L&D-owned methods ranked in the
More news about: RedThread Research
Jun 03, 2026, 10:00 ET Midwestern University Selects D2L to Support AI Innovation in Teaching and Learning
out how D2L helps transform lives and delivers outstanding learning outcomes in K-12, higher education and businesses.X: @D2L© 2026 D2L Corporation.The D2L family of companies includes D2L Inc., D2L Corporation, D2L Ltd, D2L Australia Pty Ltd, D2L Europe Ltd, D2L Asia Pte Ltd,
More news about: D2L
Jun 03, 2026, 09:58 ET Renouvellement de la marque JA : « One JA » crée un écosystème d'énergie verte pour donner plus de moyens d'action aux industries mondiales
rendre stable, accessible et abordable pour tous les secteurs d'activité, en faisant progresser la transition avec des partenaires mondiaux ».De l'« exportation de produits » au « renforcement des capacités mondiales », et de la « marque chinoise qui s'internationalise » à la « marque véritablement
More news about: JA
Jun 03, 2026, 09:50 ET Invesco High Income Trust II Announces Portfolio Management Changes
secondary market and may trade at a discount or premium to NAV. Regular brokerage commissions apply.NOT A DEPOSIT | NOT FDIC INSURED l MAY LOSE VALUE l NOT GUARANTEED BY A BANK | NOT IN INSURED BY ANY FEDERAL GOVERNMENT AGENCYContact: Matthew Chisum,
More news about: Invesco Ltd.
Jun 03, 2026, 09:43 ET ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN IMDYLLTRA® ДЛЯ ЛЕЧЕНИЯ МЕЛКОКЛЕТОЧНОГО РАКА ЛЕГКОГО НА ЗАПУЩЕННОЙ СТАДИИ
https://www.clinicaltrials.gov/study/NCT05740566.Rudin CM, Mountzios GS, Sun L, et al. Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small-cell lung cancer: primary analysis of Ph3 DeLLphi-304. Oral presentation at: ASCO Annual Meeting;
More news about: Amgen
Jun 03, 2026, 09:27 ET LA CE APRUEBA IMDYLLTRA® DE AMGEN PARA EL CÁNCER DE PULMÓN DE CÉLULAS PEQUEÑAS EN ESTADIO AVANZADO
https://www.clinicaltrials.gov/study/NCT05740566.Rudin CM, Mountzios GS, Sun L, et al. Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small-cell lung cancer: primary analysis of Ph3 DeLLphi-304. Oral presentation at: ASCO Annual Meeting;
More news about: Amgen
Jun 03, 2026, 09:16 ET Hochpräzise Basen-Editierungstherapie zeigt dauerhafte VOC-freie Wirksamkeit und günstige Sicherheit bei Sichelzellanämie
wobei am 13. Tag nach der Behandlung eine Neutrophilen-Engraftment beobachtet wurde und die Thrombozytenzahl am 21. Tag nach der Behandlung 50 × 10⁹/l überstieg. Innerhalb eines Monats nach der Behandlung stiegen die Werte des fetalen Hämoglobins (HbF) deutlich und kontinuierlich an, während die Werte
More news about: CorrectSequence Therapeutics
Jun 03, 2026, 09:16 ET Terapia de edição de bases de alta precisão demonstra eficácia duradoura sem VOCs e perfil de segurança favorável na doença falciforme
paciente alcançou uma reconstituição hematopoiética rápida e eficaz, com enxerto de neutrófilos observado no 13º dia e contagem de plaquetas superior a 50×10^9/L no 21º dia após o tratamento. No prazo de um mês após o tratamento, os níveis de hemoglobina fetal (HbF) aumentaram de forma significativa e contínua,
More news about: CorrectSequence Therapeutics
Jun 03, 2026, 09:15 ET La terapia de edición de bases de alta precisión demuestra una eficacia duradera sin VOC y una seguridad favorable en la enfermedad de células falciformes
paciente logró una reconstitución hematopoyética rápida y eficaz, y se observó un injerto de neutrófilos el día 13 y recuentos de plaquetas superiores a 50×10^9/L el día 21 después del tratamiento. En el plazo de un mes después del tratamiento, los niveles de hemoglobina fetal (HbF) aumentaron de manera significativa
More news about: CorrectSequence Therapeutics
Jun 03, 2026, 09:05 ET Une thérapie de réécriture de base de haute précision démontre une efficacité durable, sans crises vaso-occlusives et un profil d'innocuité favorable dans le traitement de la drépanocytose
reconstitution hématopoïétique rapide et efficace, avec une greffe de neutrophiles observée au 13e jour et des numérations plaquettaires dépassant 50×10^9/L au 21e jour après le traitement. Un mois après le traitement, les taux d'hémoglobine fœtale (HbF) ont augmenté de manière significative et continue,
More news about: CorrectSequence Therapeutics
Jun 03, 2026, 09:00 ET KIA ANNOUNCES PRICING FOR ALL-NEW 2027 SELTOS
choice of a 2.0-liter engine or a responsive 1.6-liter turbocharged powertrain. New for the 2027 model, bold X-Line trims are available with both the 2.0L and 1.6T engines and introduce a more rugged appearance with unique fascias, piano black fender flares, blacked-out trim and exclusive wheel designs.
More news about: Kia America
Jun 03, 2026, 09:00 ET Oscilar Launches Agent Hub, the First Unified AI Agent Platform Spanning Fraud, Compliance, Credit, and Onboarding
suggests threshold adjustments, identifies redundant rules, and surfaces new patterns to catch, all backed by data-driven impact analysis.AML L1 Review Agent: Reviews first-line AML alerts, surfaces relevant customer history and recommends dispositions, reducing analyst time on the routine
More news about: Oscilar
Jun 03, 2026, 08:47 ET CounterX Therapeutics to Present at the 88th Annual College on Problems of Drug Dependence (CPDD) Scientific Meeting
the risk of overdose and provide a path to recovery. Dr. Marco Pravetoni is the Founder and Chief Scientific Officer at CounterX Therapeutics and Rick L Seaver Professor of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine.CTRX-101:CTRX-101 is a
More news about: CounterX Therapeutics
Jun 03, 2026, 08:43 ET Vigilant Aerospace Supports National Guard Emergency Management Exercise at Camp Grafton
on the ground. FlightHorizon provides the real-time visualization and alerting to make this coordination a safe and practical reality," said Kraettli L. Epperson, CEO of Vigilant Aerospace.For additional information, contact River Cordova at
More news about: Vigilant Aerospace Systems
Jun 03, 2026, 08:34 ET Vigilant Aerospace Deploys FlightHorizon TEMPO at Infinity One Oklahoma Spaceport
system required—a standards-based, multi-sensor-ready solution that can grow with future military, cargo UAS, and air taxi operations."Kraettli L. Epperson, CEO of Vigilant Aerospace, said, "With the emergence of autonomous aircraft as both a factor in national security and the future of the aviation
More news about: Vigilant Aerospace Systems